{"gene":"PAK4","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1998,"finding":"PAK4 was identified as a novel effector for Cdc42Hs, interacting only with the activated (GTP-bound) form through its GTPase-binding domain (GBD). Co-expression with constitutively active Cdc42HsV12 redistributes PAK4 to the Golgi membrane and induces filopodia and actin polymerization in a kinase activity-dependent manner.","method":"Co-expression, co-immunoprecipitation, dominant-negative/active mutants, immunofluorescence localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — original discovery paper, multiple orthogonal methods, widely replicated","pmids":["9822598"],"is_preprint":false},{"year":2001,"finding":"Serine 474 in the PAK4 kinase domain was identified as an autophosphorylation site in vivo; the S474E mutation confers constitutive kinase activation, and activated PAK4 (S474E) transforms NIH3T3 cells for anchorage-independent growth, while kinase-inactive PAK4 (K350A/K351A) blocks Ras-driven transformation.","method":"Phosphospecific antibody generation, site-directed mutagenesis, soft agar colony assay, co-expression with activated Cdc42","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo phosphorylation mapping with mutagenesis and functional validation","pmids":["11668177"],"is_preprint":false},{"year":2001,"finding":"PAK4 protects cells from apoptosis by phosphorylating the proapoptotic protein Bad, leading to inhibition of caspase activation. Expression of wild-type or constitutively active PAK4 delays apoptosis induced by TNF-α, UV irradiation, and serum starvation.","method":"Overexpression of wild-type and constitutively active PAK4 mutants, phosphorylation assay of Bad, caspase activation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple stimuli tested, direct substrate phosphorylation demonstrated, replicated in subsequent studies","pmids":["11278822"],"is_preprint":false},{"year":2001,"finding":"Constitutively active PAK4 dissolves actin stress fibers and focal adhesions, impairs cell spreading on fibronectin, and induces anchorage-independent growth in fibroblasts. Dominant-negative PAK4 inhibits Dbl-induced focus formation, placing PAK4 downstream of Rho GTPase exchange factors in oncogenic transformation.","method":"Expression of activated/dominant-negative PAK4 mutants, soft agar assay, focus formation assay, immunofluorescence","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — epistasis with dominant-negative mutants, multiple cellular readouts, replicated","pmids":["11313478"],"is_preprint":false},{"year":2003,"finding":"PAK4 knockout in mice causes embryonic lethality by E11.5 with defects in fetal heart development and spinal cord motor neuron/interneuron differentiation and migration, establishing PAK4 as essential for neuronal development and cytoskeletal organization in vivo.","method":"Gene knockout (homologous recombination), histological analysis, phenotypic characterization of PAK4-null embryos","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with specific developmental phenotypes","pmids":["14517283"],"is_preprint":false},{"year":2003,"finding":"PAK4 inhibits death receptor-induced apoptosis by antagonizing initiator caspase 8 activation, independent of PAK4 kinase activity, potentially by blocking caspase 8 recruitment to death domain receptors (TNF-R, Fas).","method":"Overexpression of kinase-active and kinase-dead PAK4, caspase 8 activity assay, apoptosis assay with TNF-α/Fas stimulation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — kinase-independent mechanism defined by mutagenesis, single lab","pmids":["14560027"],"is_preprint":false},{"year":2005,"finding":"Endogenous PAK4 is required for optimal TRADD binding to the activated TNF-α receptor through both kinase-dependent and kinase-independent mechanisms, thereby enabling full activation of NF-κB and ERK pro-survival pathways downstream of TNF-α.","method":"RNAi knockdown of endogenous PAK4, co-immunoprecipitation of TRADD with TNF-R, NF-κB and ERK pathway assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — endogenous knockdown with specific Co-IP readout, single lab","pmids":["16227624"],"is_preprint":false},{"year":2006,"finding":"PAK4 and alphaPIX regulate podosome size and number in primary human macrophages; kinase-active PAK4 increases podosome size while kinase-inactive PAK4 decreases it, demonstrating kinase activity-dependent regulation of localized actin dynamics at podosomes.","method":"Immunofluorescence, shRNA knockdown, transfection of kinase-active/-inactive PAK4 mutants, microarray","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — primary cell system, kinase mutant analysis, single lab","pmids":["16897755"],"is_preprint":false},{"year":2007,"finding":"Crystal structures of active, monophosphorylated PAK4 catalytic domain (along with PAK5 and PAK6) revealed domain plasticity including rearrangements of helix αC with an additional helical turn, forming interactions that link the glycine-rich loop, αC, and the activation segment to anchor αC in an active conformation. A tri-substituted purine inhibitor was co-crystallized with PAK4.","method":"X-ray crystallography (multiple high-resolution structures), inhibitor co-crystallization","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — multiple crystal structures with functional interpretation and inhibitor co-crystal","pmids":["17292838"],"is_preprint":false},{"year":2008,"finding":"PAK4 binds to and phosphorylates LIMK1 in an HGF-dependent manner in prostate cancer cells, altering cofilin phosphorylation levels, cell morphology, and migration speed. PAK4 and LIMK1 interact in small foci at the cell periphery as confirmed by FRET-FLIM.","method":"Co-immunoprecipitation, in vitro kinase assay, FRET-FLIM, siRNA knockdown, cell migration assay","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation shown, FRET-FLIM localization, multiple methods","pmids":["18424072"],"is_preprint":false},{"year":2008,"finding":"The PAK4-JNK signaling pathway acts as a negative regulator of Streptococcus pneumoniae pneumolysin-induced MUC5AC mucin transcription; MKP1 inhibits this PAK4-JNK pathway (induced via TLR4-MyD88-TRAF6-ERK) to upregulate MUC5AC production.","method":"Signaling pathway inhibitor studies, mucosal epithelial cell assays, MUC5AC transcription reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — pathway epistasis defined, single lab","pmids":["18782768"],"is_preprint":false},{"year":2010,"finding":"PAK4 localizes at focal adhesions, co-immunoprecipitates with paxillin, and directly phosphorylates paxillin on serine 272, regulating focal adhesion turnover and cell migration in prostate cancer cells. PAK4 also regulates RhoA activity via GEF-H1.","method":"Co-immunoprecipitation, in vitro kinase assay, immunofluorescence localization, siRNA knockdown, cell migration assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1-2 — direct substrate phosphorylation, localization, and functional validation","pmids":["20406887"],"is_preprint":false},{"year":2010,"finding":"Cdc42-dependent recruitment of PAK4 to nascent cell-cell contacts is required for the maturation of primordial junctions into apical junctions in human bronchial epithelial cells; PAK4 kinase activity is essential for junction maturation, and Par6B/aPKC retains PAK4 at junction sites.","method":"siRNA library screen of 36 Cdc42 targets, immunofluorescence, dominant-active PAK4 overexpression","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — systematic siRNA screen, kinase mutant validation, multiple cellular readouts","pmids":["20631255"],"is_preprint":false},{"year":2011,"finding":"CDK5RAP3 is a novel binding partner of PAK4 that enhances PAK4 kinase activity; PAK4 knockdown in CDK5RAP3-overexpressing HCC cells reverses CDK5RAP3-mediated enhanced invasiveness, placing PAK4 as an essential downstream effector of CDK5RAP3.","method":"Co-immunoprecipitation, siRNA knockdown, in vitro kinase assay, invasion assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — direct interaction and kinase activation demonstrated, single lab","pmids":["21385901"],"is_preprint":false},{"year":2011,"finding":"PAK4 is a nucleo-cytoplasmic shuttling protein containing three nuclear export signals (NESs) and two nuclear localization signals (NLSs); it is exported via CRM-1-dependent pathway and imported via importin α5. Nuclear PAK4 phosphorylates β-catenin on Ser675, stabilizes β-catenin, promotes TCF/LEF transcriptional activity, and associates with the TCF/LEF transcriptional complex at chromatin.","method":"Deletion mutant analysis, nuclear/cytoplasmic fractionation, co-immunoprecipitation, phosphorylation assay, ChIP, luciferase reporter assay","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including ChIP and in vitro phosphorylation","pmids":["22173096"],"is_preprint":false},{"year":2011,"finding":"Conditional nervous system-specific knockout of Pak4 (nestin-Cre) causes reduced proliferation and self-renewal of cortical and striatal neural progenitor cells, cortical thinning, impaired neurogenesis, and loss of neuroepithelial adherens junctions, establishing PAK4 as essential for neural progenitor cell proliferation and brain development.","method":"Conditional knockout (Cre-lox), BrdU proliferation assay, neurosphere culture, histological analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — conditional genetic knockout with defined cellular phenotypes","pmids":["21382368"],"is_preprint":false},{"year":2011,"finding":"Conditional deletion of PAK4 in secondary heart field progenitors causes abnormal outflow tract development and cardiomyocytes depleted of PAK4 show reduced LIMK1 levels and severely compromised sarcomeric structure, placing PAK4 upstream of LIMK1 in cardiac cytoskeletal organization.","method":"Conditional knockout, histological/echocardiographic analysis, PAK4 knockdown in cultured cardiomyocytes, LIMK1 western blot","journal":"Transgenic research","confidence":"Medium","confidence_rationale":"Tier 2 — conditional knockout with molecular readout (LIMK1), single lab","pmids":["22173944"],"is_preprint":false},{"year":2012,"finding":"PAK4 directly interacts with MMP-2 through its kinase domain (demonstrated by GST pull-down), and PAK4 regulates αvβ3-integrin and phospho-EGFR survival signaling in glioma cells; dual PAK4/MMP-2 depletion causes robust anoikis-mediated cell death.","method":"GST pull-down, siRNA knockdown, anoikis assay, cDNA-PCR arrays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 — direct interaction by pull-down, functional epistasis, single lab","pmids":["23254288"],"is_preprint":false},{"year":2012,"finding":"PAK4 depletion results in defective astral microtubule networks, failure of spindle centering, and prolonged metaphase-like state with chromosome scattering; PAK4 regulates dynein/dynactin complex localization at kinetochores and on astral microtubules, establishing PAK4 as required for metaphase spindle positioning and anchoring.","method":"siRNA knockdown, live cell imaging, immunofluorescence, spindle orientation analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — clean depletion with specific mechanistic readout (dynein/dynactin), single lab","pmids":["22450748"],"is_preprint":false},{"year":2013,"finding":"PAK4 interacts with Smad2/3 via a kinase-independent mechanism that blocks TGF-β1-induced phosphorylation of Smad2 Ser465/467 and Smad3 Ser423/425. Additionally, PAK4 phosphorylates Smad2 on Ser465, leading to its ubiquitin-proteasome-dependent degradation under HGF stimulation.","method":"Co-immunoprecipitation, in vitro kinase assay, ubiquitination assay, kinase-inactive mutant analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation and ubiquitin-mediated degradation demonstrated with multiple methods","pmids":["23934187"],"is_preprint":false},{"year":2013,"finding":"PAK4 kinase phosphorylates SCG10 (stathmin-2) on serine 50, regulating microtubule dynamics to promote gastric cancer cell migration and invasion; inhibition of PAK4 by LCH-7749944 or RNAi blocks Ser50 phosphorylation and cell invasion.","method":"In vitro kinase assay, site-directed mutagenesis, phospho-specific antibody, xenograft mouse model, siRNA knockdown","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — direct substrate phosphorylation with mutagenesis and in vivo validation","pmids":["23893240"],"is_preprint":false},{"year":2013,"finding":"SH3RF2 binds PAK4 and inhibits its ubiquitin-proteasome-dependent degradation through steric hindrance, stabilizing PAK4 protein levels. Loss of SH3RF2 reduces TRADD recruitment to TNF-R1 and impairs NF-κB signaling, consistent with PAK4 stabilization being required for these downstream effects.","method":"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment, siRNA knockdown","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — direct interaction and ubiquitination suppression demonstrated, single lab","pmids":["24130170"],"is_preprint":false},{"year":2014,"finding":"NDRG1 reduces nuclear localization of PAK4, thereby inhibiting PAK4-dependent nuclear translocation of β-catenin and downstream TCF/LEF transcriptional activity; this defines a NDRG1→PAK4→β-catenin nuclear transport axis.","method":"Nuclear/cytoplasmic fractionation, Co-immunoprecipitation, reporter assay, immunofluorescence","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway placement, multiple methods, single lab","pmids":["24829151"],"is_preprint":false},{"year":2015,"finding":"PAK4 phosphorylates Par6B at Ser143, blocking Par6B's interaction with Cdc42, providing a feedback mechanism to control Par6B subcellular localization and polarity complex formation in apical junction assembly.","method":"In vitro kinase assay, site-directed mutagenesis, co-immunoprecipitation, immunofluorescence","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct phosphorylation with mutagenesis, single lab","pmids":["25662318"],"is_preprint":false},{"year":2015,"finding":"PAK4 stabilizes RhoU protein in a kinase-independent manner by protecting it from ubiquitination by the Rab40A-Cullin 5 E3 ligase complex; RhoU overexpression rescues the PAK4 depletion adhesion-turnover phenotype, defining a kinase-independent scaffolding function of PAK4.","method":"siRNA depletion, ubiquitination assay, RhoU rescue experiment, co-immunoprecipitation, cell adhesion/migration assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway defined with rescue experiment and ubiquitination assay, multiple methods","pmids":["26598620"],"is_preprint":false},{"year":2015,"finding":"In cellulo crystal structure of human PAK4 catalytic domain in complex with its endogenous inhibitor Inka1 was determined at 2.95 Å resolution, revealing how the PAK4 catalytic domain binds cellular ATP and Inka1. The PAK4-PAK4 lattice forms a hexagonal array accommodating other proteins fused to Inka1.","method":"In cellulo X-ray crystallography, live-cell crystal imaging with Inka1-GFP","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — in cellulo crystal structure at 2.95 Å with functional inhibitor complex","pmids":["26607847"],"is_preprint":false},{"year":2015,"finding":"Integrin αvβ3 recruits and activates PAK4 to counteract senescence in glioblastoma cells; targeting either αvβ3 or PAK4 leads to p21-dependent, p53-independent cell senescence, establishing an αvβ3→PAK4 axis that enables glioblastoma cells to evade oncogene-induced senescence.","method":"RNAi knockdown, genetic deletion, senescence assay (SA-β-galactosidase), p21/p53 analysis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis defined by dual knockdown, specific senescence phenotype, single lab","pmids":["26297735"],"is_preprint":false},{"year":2016,"finding":"SETD6 methyltransferase methylates PAK4 both in vitro and at chromatin in cells; SETD6 methylation of PAK4 dramatically increases the PAK4-β-catenin physical interaction and promotes transcription of Wnt/β-catenin target genes.","method":"In vitro methylation assay, co-immunoprecipitation, luciferase reporter assay, ChIP, siRNA depletion of SETD6","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro and in cellulo methylation demonstrated, chromatin association shown, multiple methods","pmids":["26841865"],"is_preprint":false},{"year":2016,"finding":"Drosophila Pak4/Mbt phosphorylates β-catenin/Armadillo to regulate AJ morphogenesis and stability during zonula adherens remodeling; this β-catenin phosphorylation is required for retention of Par3/Bazooka at the remodeling ZA and cooperates with Par1-dependent lateral exclusion to regulate apical membrane differentiation.","method":"Conditional genetics, phosphorylation assay, immunofluorescence in Drosophila epithelium, AJ morphogenesis assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — direct substrate phosphorylation in a genetic model, replicated by structure in mammalian system","pmids":["27052178"],"is_preprint":false},{"year":2016,"finding":"PAK4 promotes neuroprotection of dopaminergic neurons by phosphorylating CRTC1 (CREB-regulated transcription coactivator) at S215; non-phosphorylatable CRTC1-S215A abolishes the ability of constitutively active PAK4 to induce Bcl-2, BDNF, and PGC-1α expression through CREB, defining a PAK4→CRTC1-S215→CREB neuroprotective axis.","method":"Constitutively active PAK4 expression, site-directed mutagenesis of CRTC1, viral delivery in rat PD models, Western blot for CREB targets","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1-2 — direct substrate phosphorylation with mutagenesis and in vivo validation in rat models","pmids":["27903866"],"is_preprint":false},{"year":2017,"finding":"PAK4 phosphorylates N-WASP at Ser484/Ser485 and promotes Arp2/3-dependent actin polymerization in vitro; PAK4 ablation reduces N-WASP phosphorylation and alters the G-actin/F-actin balance and actin organization in cells. The PAK4 interactome (by iTRAQ mass spectrometry) is enriched in 14-3-3, proteasome, replication fork, CCT, and Arp2/3 complexes.","method":"iTRAQ quantitative MS of PAK4 immunoprecipitations, in vitro kinase assay, in vitro actin polymerization assay, PAK4 ablation","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro actin polymerization, direct phosphorylation site identified, systematic interactome","pmids":["29100370"],"is_preprint":false},{"year":2017,"finding":"PAK4 regulates G6PD activity and cellular pentose phosphate pathway flux by enhancing Mdm2-mediated ubiquitination and degradation of p53, thereby promoting glucose uptake, NADPH production, and lipid biosynthesis in colon cancer cells.","method":"Co-immunoprecipitation, ubiquitination assay, G6PD activity assay, metabolic flux analysis, siRNA knockdown","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway defined with enzymatic and ubiquitination assays, single lab","pmids":["28542136"],"is_preprint":false},{"year":2017,"finding":"PAK4 interacts with the p85α regulatory subunit of PI3K; PAK4-deficient pancreatic cancer cells show reduced Akt phosphorylation downstream of HGF signaling, implicating PAK4 within the PI3K/Akt pathway via p85α.","method":"Co-immunoprecipitation, siRNA knockdown, Western blot for p-Akt, HGF-stimulated migration assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP with functional correlation, single lab","pmids":["28205613"],"is_preprint":false},{"year":2017,"finding":"Zic2 transcription factor directly binds the PAK4 promoter and activates PAK4 transcription (shown by ChIP and luciferase assay); PAK4 mediates Zic2-driven HCC cell growth via the Raf/MEK/ERK pathway.","method":"ChIP assay, luciferase reporter assay, siRNA knockdown epistasis, MEK/ERK pathway inhibition","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding confirmed by ChIP and reporter, pathway epistasis, single lab","pmids":["28577975"],"is_preprint":false},{"year":2018,"finding":"Crystal structure and solution scattering of full-length PAK4 in complex with CDC42 revealed that beyond the canonical CRIB domain interaction, the PAK4 kinase C-lobe and polybasic region also contact CDC42, increasing binding affinity for full-length PAK4 and modulating kinase activity.","method":"X-ray crystallography, small-angle X-ray scattering (SAXS), kinase activity assay, binding affinity measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation of extended interface","pmids":["29295922"],"is_preprint":false},{"year":2019,"finding":"PAK4 phosphorylates CEBPB on Thr-235, which activates CEBPB-mediated transcription of claudin-4 (CLDN4), promoting breast cancer cell migration and invasion in a PAK4-CEBPB-CLDN4 axis.","method":"siRNA knockdown, luciferase reporter assay (CLDN4 promoter), Western blot for p-CEBPB, rescue experiments","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — phosphorylation site and transcriptional axis defined, single lab","pmids":["30808546"],"is_preprint":false},{"year":2019,"finding":"Nuclear PAK4 (nPAK4) co-translocates with ERα from cytoplasm to nucleus upon 17β-estradiol stimulation, represses ERα-mediated transactivation, and promotes bone metastasis of ER+ breast cancer cells by targeting LIFR (a bone metastasis suppressor) through a PAK4-ERα nuclear axis.","method":"Nuclear/cytoplasmic fractionation, co-immunoprecipitation, ChIP, luciferase reporter, in vivo metastasis model","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — nuclear co-translocation and chromatin association demonstrated, single lab","pmids":["30177834"],"is_preprint":false},{"year":2019,"finding":"PAK4 phosphorylates fumarase (FH) at Ser46, causing FH to bind 14-3-3 protein and become sequestered in the cytosol, thereby preventing formation of the FH/CSL/p53 nuclear complex that drives p21 transcription and TGF-β-induced cell growth arrest in lung cancer cells.","method":"In vitro kinase assay, site-directed mutagenesis, co-immunoprecipitation, ChIP, cell growth arrest assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation with mutagenesis, 14-3-3 binding, and nuclear complex formation shown","pmids":["30683654"],"is_preprint":false},{"year":2019,"finding":"PAK4 phosphorylates CRTC1 at S215 to activate CREB signaling and protect motor neurons from degeneration; the PAK4/CREB pathway is inhibited in ALS models and PAK4 overexpression in spinal neurons of hSOD1G93A rats suppresses motor neuron degeneration and prolongs survival.","method":"Constitutively active PAK4 overexpression, CREB inhibitor experiments, in vivo spinal injection, rotarod motor function test, apoptosis assay","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo rescue with defined molecular pathway, single lab","pmids":["33615605"],"is_preprint":false},{"year":2020,"finding":"SETD6-mediated methylation of PAK4 at lysine 473 (K473) activates β-catenin transcriptional activity and inhibits cell adhesion by reducing paxillin localization to focal adhesions, decreasing filopodia, actin structures, and cell migration/invasion.","method":"Site-directed mutagenesis (K473 methylation site), immunofluorescence of focal adhesions/paxillin, β-catenin reporter assay, cell adhesion assay","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — specific methylation site identified with mutagenesis, multiple downstream readouts","pmids":["33051544"],"is_preprint":false},{"year":2020,"finding":"PAK4 reprograms glioblastoma tumor endothelial cells through a MEF2D/ZEB1- and SLUG-mediated mechanism that downregulates claudin-14 and VCAM-1 expression, enhancing vessel permeability and reducing T cell adhesion to the endothelium; PAK4 knockout in ECs reduces vascular abnormalities and improves T cell infiltration.","method":"PAK4 knockout in ECs, transcriptome analysis, ChIP for MEF2D/ZEB1/SLUG at claudin-14 and VCAM-1 promoters, T cell adhesion assay, in vivo tumor models","journal":"Nature cancer","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout, transcriptomic profiling, ChIP mechanistic validation, in vivo","pmids":["35121889"],"is_preprint":false},{"year":2021,"finding":"CDK15 binds PAK4 and phosphorylates it at Ser291, promoting colorectal cancer cell proliferation and anchorage-independent growth through β-catenin/c-Myc and MEK/ERK signaling pathways; PAK4 inhibition reverses CDK15-driven tumorigenesis.","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis (S291), CDK15 knockout in mice (AOM/DSS model), PDX model","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation site identified with in vitro assay, mutagenesis, and in vivo validation","pmids":["34262144"],"is_preprint":false},{"year":2021,"finding":"BioID proximity proteomics revealed that PAK4 is enriched at Afadin/Nectin junctions; PAK4 depends on Afadin for junctional localization. Phosphoproteomics after PAK4 inhibitor treatment identified 17 PAK4 phosphorylation sites on junctional proteins, defining PAK4 as selective for the Afadin/nectin sub-compartment.","method":"BioID proximity labeling, quantitative mass spectrometry, co-immunoprecipitation, phosphoproteomics with PAK4 inhibitors, immunofluorescence","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — systematic proximity proteomics, phosphoproteomics, and localization studies","pmids":["34493720"],"is_preprint":false},{"year":2010,"finding":"PAK4 N-terminal domain associates with ribonucleoprotein (RNP) complexes and active PAK4 can affect cap-independent (IRES-mediated) translation in vivo; the N-terminal domain also contains nuclear export signals and cytoplasmic targeting elements, with endogenous PAK4 found in both cytoplasmic and nuclear fractions.","method":"Affinity chromatography, co-immunoprecipitation with RNP components, IRES-mediated translation reporter assay, subcellular fractionation","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2-3 — novel function shown by direct binding and functional reporter, single lab","pmids":["20578242"],"is_preprint":false},{"year":2018,"finding":"VIP and secretin activate PAK4 in pancreatic acinar cells via cAMP pathways (VIP via EPAC; secretin via PKA), and PAK4 activation is required for subsequent Na+,K+-ATPase activation and pancreatic fluid secretion.","method":"Selective cAMP pathway inhibitors (KT-5720, PKI, ESI-09, HJC0197), PAK4 inhibitors (PF-3758309, LCH-7749944), PAK4 kinase activity assay, Na+,K+-ATPase activity assay","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with multiple inhibitors, functional readout","pmids":["30520694"],"is_preprint":false}],"current_model":"PAK4 is a Cdc42-activated serine/threonine kinase that signals downstream of Rho-family GTPases to regulate actin cytoskeletal organization (via LIMK1/cofilin, N-WASP/Arp2/3, paxillin, and RhoU stabilization), cell survival (phosphorylating Bad and CRTC1/CREB, antagonizing caspase 8), Wnt/β-catenin transcription (phosphorylating β-catenin at Ser675 and undergoing SETD6-mediated lysine methylation that further enhances β-catenin interaction), and cell proliferation/transformation; its activity is modulated by CDK15-mediated phosphorylation at Ser291 and SETD6-mediated methylation at K473, and it functions both as a kinase and as a kinase-independent scaffold (stabilizing RhoU from Rab40A-Cullin5-mediated ubiquitination) with localization to Golgi, focal adhesions, cell-cell junctions (particularly the Afadin/nectin compartment), and the nucleus."},"narrative":{"teleology":[{"year":1998,"claim":"The identification of PAK4 as a novel Cdc42 effector that localizes to the Golgi and induces filopodia established that a distinct group II PAK kinase links Rho-family GTPase signaling to actin cytoskeletal remodeling.","evidence":"Co-immunoprecipitation of PAK4 with GTP-bound Cdc42, immunofluorescence showing Golgi relocalization and filopodia induction in transfected cells","pmids":["9822598"],"confidence":"High","gaps":["Endogenous substrates mediating actin remodeling were unknown","Physiological activation context beyond overexpression was undefined"]},{"year":2001,"claim":"Mapping the Ser474 autophosphorylation site as the activating event, and demonstrating that constitutively active PAK4 transforms fibroblasts while kinase-dead PAK4 blocks Ras transformation, established PAK4 as an oncogenic kinase and defined its activation mechanism.","evidence":"Phosphospecific antibody, S474E constitutive activation mutant, soft agar colony formation and focus formation assays","pmids":["11668177","11313478"],"confidence":"High","gaps":["Upstream signals triggering Ser474 autophosphorylation in vivo were unclear","Direct transformation targets were unidentified"]},{"year":2001,"claim":"Demonstrating that PAK4 phosphorylates Bad and inhibits caspase activation provided the first direct survival substrate, while a subsequent study showed kinase-independent caspase-8 antagonism, revealing dual mechanisms for anti-apoptotic function.","evidence":"Bad phosphorylation assay, caspase activity assays under TNF-α/UV/serum deprivation, kinase-dead mutant retaining caspase-8 inhibition","pmids":["11278822","14560027"],"confidence":"High","gaps":["The precise kinase-independent mechanism for caspase-8 inhibition was not structurally resolved","Whether Bad phosphorylation is direct in endogenous settings was not confirmed"]},{"year":2003,"claim":"PAK4 knockout embryonic lethality with cardiac and neural defects proved that PAK4 is non-redundant with other PAK family members for vertebrate development, particularly for heart and spinal cord morphogenesis.","evidence":"Homologous recombination knockout, histological analysis of E11.5 embryos","pmids":["14517283"],"confidence":"High","gaps":["Which PAK4 substrates mediate the cardiac versus neuronal phenotypes was unknown","Conditional tissue-specific requirements had not yet been dissected"]},{"year":2005,"claim":"Showing that endogenous PAK4 promotes TRADD recruitment to TNF-R1 and activates NF-κB/ERK pathways placed PAK4 as an upstream organizer of TNF receptor signaling complexes, not merely an anti-apoptotic effector.","evidence":"RNAi knockdown of endogenous PAK4, TRADD co-immunoprecipitation with TNF-R, NF-κB and ERK assays","pmids":["16227624"],"confidence":"Medium","gaps":["Whether PAK4 directly phosphorylates TRADD or a scaffold component was not determined","Single-lab finding without independent replication"]},{"year":2007,"claim":"Crystal structures of the active PAK4 catalytic domain revealed the structural basis for group II PAK activation, including αC helix rearrangements that distinguish it from group I PAKs, and enabled structure-based inhibitor design.","evidence":"Multiple X-ray crystal structures including inhibitor co-crystal","pmids":["17292838"],"confidence":"High","gaps":["Full-length PAK4 structure with autoinhibitory domain was not resolved","How Cdc42 binding allosterically activates the kinase domain was structurally undefined"]},{"year":2008,"claim":"Identification of LIMK1 as a direct PAK4 substrate linking HGF signaling to cofilin phosphorylation and cell migration established the PAK4→LIMK1→cofilin pathway as a core actin regulatory axis.","evidence":"In vitro kinase assay, FRET-FLIM co-localization at cell periphery, siRNA and migration assays in prostate cancer cells","pmids":["18424072"],"confidence":"High","gaps":["Specific LIMK1 phosphorylation site(s) by PAK4 were not mapped","Whether this pathway operates in non-cancer contexts was untested"]},{"year":2010,"claim":"Demonstrating that PAK4 phosphorylates paxillin at Ser272 at focal adhesions and is recruited to cell-cell junctions via Cdc42 for junction maturation expanded PAK4's role from actin dynamics to adhesion-dependent signaling at two distinct subcellular compartments.","evidence":"In vitro kinase assay and immunofluorescence for paxillin; siRNA screen of 36 Cdc42 targets for junction maturation in bronchial epithelial cells","pmids":["20406887","20631255"],"confidence":"High","gaps":["How PAK4 is differentially targeted to focal adhesions versus junctions was unclear","The junctional substrates downstream of PAK4 at cell-cell contacts were unidentified"]},{"year":2011,"claim":"Discovery that PAK4 shuttles between nucleus and cytoplasm via CRM1/importin-α5 and phosphorylates nuclear β-catenin at Ser675 to activate TCF/LEF transcription established a direct role for PAK4 in Wnt pathway transcriptional output.","evidence":"Deletion mutant mapping of NLS/NES, nuclear fractionation, ChIP showing PAK4 at TCF/LEF-bound chromatin, β-catenin Ser675 phosphorylation assay","pmids":["22173096"],"confidence":"High","gaps":["Which Wnt ligands activate this nuclear PAK4 pool was unknown","Whether nuclear PAK4 kinase activity is regulated differently from cytoplasmic activity was not addressed"]},{"year":2011,"claim":"Conditional neural knockout revealed that PAK4 is essential for cortical progenitor proliferation, neurosphere self-renewal, and adherens junction maintenance, connecting its junctional and cytoskeletal functions to brain development.","evidence":"Nestin-Cre conditional knockout, BrdU proliferation assay, neurosphere culture, histological analysis","pmids":["21382368"],"confidence":"High","gaps":["Downstream substrates responsible for neural progenitor proliferation were not identified","Whether cardiac-specific conditional knockout phenocopies the global knockout heart defect was only partially addressed"]},{"year":2013,"claim":"Identification of Smad2/3 as PAK4 substrates and interactors, with PAK4 phosphorylation triggering Smad2 ubiquitin-dependent degradation, revealed a mechanism by which HGF/PAK4 antagonizes TGF-β tumor-suppressive signaling.","evidence":"Co-immunoprecipitation, in vitro kinase assay, ubiquitination assay with kinase-dead controls","pmids":["23934187"],"confidence":"High","gaps":["The E3 ligase mediating Smad2 degradation downstream of PAK4 was not identified","In vivo relevance in tumor models was not tested"]},{"year":2015,"claim":"Demonstrating that PAK4 stabilizes RhoU by preventing Rab40A-Cullin5-mediated ubiquitination, and that RhoU rescues PAK4 depletion adhesion phenotypes, established a kinase-independent scaffolding function distinct from PAK4's catalytic roles.","evidence":"Ubiquitination assay, RhoU rescue of PAK4-depleted cells, co-immunoprecipitation","pmids":["26598620"],"confidence":"High","gaps":["Structural basis for how PAK4 shields RhoU from the E3 ligase was unknown","Whether other substrates of Rab40A-Cullin5 are similarly protected was not investigated"]},{"year":2016,"claim":"SETD6-mediated methylation of PAK4 at K473 was shown to enhance β-catenin binding and Wnt target transcription, establishing lysine methylation as a post-translational regulatory layer on PAK4 that modulates its transcriptional functions and adhesion properties.","evidence":"In vitro methylation assay, ChIP for PAK4/β-catenin at Wnt target promoters, focal adhesion and migration assays with K473 mutants","pmids":["26841865","33051544"],"confidence":"High","gaps":["Conditions under which SETD6 methylates PAK4 physiologically were not defined","Whether demethylases reverse this modification was unknown"]},{"year":2016,"claim":"Identification of CRTC1-Ser215 as a PAK4 substrate that activates CREB-dependent expression of Bcl-2, BDNF, and PGC-1α in dopaminergic neurons defined a PAK4→CRTC1→CREB neuroprotective signaling axis with therapeutic implications for neurodegeneration.","evidence":"Site-directed mutagenesis of CRTC1 S215, viral delivery of constitutively active PAK4 in rat Parkinson's disease models, Western blot for CREB targets","pmids":["27903866"],"confidence":"High","gaps":["Endogenous upstream activators of PAK4 in neurons were not defined","Long-term neuroprotective efficacy was not assessed"]},{"year":2017,"claim":"N-WASP phosphorylation at Ser484/485 by PAK4, promoting Arp2/3-dependent actin polymerization in vitro, and a systematic PAK4 interactome enriched in actin regulators, proteasome, and replication fork components, broadened the substrate repertoire and pointed to additional PAK4 functions.","evidence":"In vitro kinase assay, reconstituted actin polymerization assay, iTRAQ quantitative mass spectrometry of PAK4 immunoprecipitates","pmids":["29100370"],"confidence":"High","gaps":["Many interactome hits (replication fork, CCT) were not functionally validated","In vivo relevance of N-WASP Ser484/485 phosphorylation was not tested"]},{"year":2018,"claim":"The crystal structure of full-length PAK4 in complex with CDC42 revealed additional contacts beyond the CRIB domain — involving the kinase C-lobe and polybasic region — explaining higher affinity of full-length PAK4 for Cdc42 and resolving how GTPase binding modulates kinase activity.","evidence":"X-ray crystallography, SAXS, binding affinity measurements, kinase assays","pmids":["29295922"],"confidence":"High","gaps":["How the autoinhibitory domain is released upon Cdc42 binding at a conformational dynamics level was not captured","Structures with downstream substrates bound were not obtained"]},{"year":2019,"claim":"PAK4 phosphorylation of fumarase at Ser46 sequesters it in the cytoplasm via 14-3-3 binding, preventing nuclear FH/CSL/p53-driven p21 transcription, revealing a mechanism by which PAK4 overrides metabolic tumor-suppressive checkpoints.","evidence":"In vitro kinase assay, S46A mutagenesis, 14-3-3 co-immunoprecipitation, ChIP for nuclear FH complex","pmids":["30683654"],"confidence":"High","gaps":["Whether this mechanism operates in normal non-cancer physiology was not tested","The quantitative contribution of FH phosphorylation to overall PAK4 oncogenicity was not established"]},{"year":2020,"claim":"Demonstrating that PAK4 reprograms tumor endothelial cells via MEF2D/ZEB1/SLUG-mediated downregulation of claudin-14 and VCAM-1, impairing T cell adhesion and infiltration, established PAK4 as a cell-non-autonomous regulator of anti-tumor immunity.","evidence":"PAK4 knockout in endothelial cells, transcriptome analysis, ChIP for MEF2D/ZEB1/SLUG at target promoters, T cell adhesion assay, in vivo glioblastoma models","pmids":["35121889"],"confidence":"High","gaps":["Whether PAK4 directly phosphorylates MEF2D or acts indirectly was not resolved","Relevance to non-brain tumor vasculature was not tested"]},{"year":2021,"claim":"CDK15 was identified as an upstream kinase phosphorylating PAK4 at Ser291 to drive β-catenin/c-Myc and MEK/ERK signaling in colorectal cancer, and BioID proximity proteomics placed PAK4 specifically at the Afadin/nectin junctional sub-compartment with 17 junctional phosphosubstrates.","evidence":"CDK15 in vitro kinase assay with S291 mutagenesis, AOM/DSS mouse model, PDX model; BioID proximity labeling, quantitative phosphoproteomics with PAK4 inhibitors","pmids":["34262144","34493720"],"confidence":"High","gaps":["How CDK15-mediated Ser291 phosphorylation changes PAK4 structure or substrate selectivity was unknown","Functional validation of the 17 junctional phosphosites was incomplete"]},{"year":null,"claim":"The mechanisms by which PAK4 selectively partitions between its junctional, focal adhesion, nuclear, and Golgi pools, and how post-translational modifications (K473 methylation, S291 phosphorylation, S474 autophosphorylation) coordinately tune substrate selectivity in each compartment, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No integrated model of compartment-specific PAK4 regulation exists","In vivo substrate phosphoproteomics across tissues is lacking","Whether PAK4's kinase-independent scaffolding functions extend beyond RhoU stabilization and caspase-8 inhibition is unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,2,9,11,14,19,20,23,29,30,35,37,39,41]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,24]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[9,11,30]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[14,22,36,43]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14,43]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[12,42]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,6,32,34,41,44]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,5]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[12,23,42]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[14,27,33,36]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,15,16]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[18]}],"complexes":["Afadin/nectin junctional complex","Par6B/aPKC polarity complex"],"partners":["CDC42","LIMK1","WASL","PXN","CTNNB1","AFDN","SETD6","RHOU"],"other_free_text":[]},"mechanistic_narrative":"PAK4 is a Cdc42-activated serine/threonine kinase that functions as a central integrator of cytoskeletal remodeling, cell survival, cell polarity, and transcriptional regulation downstream of Rho-family GTPases. Upon binding GTP-loaded Cdc42, PAK4 autophosphorylates at Ser474 to become catalytically active and phosphorylates diverse substrates including LIMK1 and N-WASP (driving Arp2/3-dependent actin polymerization), paxillin (regulating focal adhesion turnover), β-catenin at Ser675 (promoting Wnt/TCF/LEF transcription), Bad (inhibiting apoptosis), CRTC1 at Ser215 (activating CREB-dependent neuroprotective gene expression), and Smad2 (triggering its degradation to antagonize TGF-β signaling) [PMID:9822598, PMID:11668177, PMID:18424072, PMID:20406887, PMID:22173096, PMID:27903866, PMID:23934187, PMID:29100370]. PAK4 also operates through kinase-independent scaffolding, notably stabilizing RhoU by shielding it from Rab40A-Cullin5-mediated ubiquitination and antagonizing caspase-8 activation at death receptors [PMID:26598620, PMID:14560027]. Its activity is modulated by SETD6-mediated lysine methylation at K473, which enhances β-catenin interaction and Wnt target gene transcription while reducing focal adhesion integrity, and by CDK15-mediated phosphorylation at Ser291, which promotes β-catenin/c-Myc and MEK/ERK signaling [PMID:26841865, PMID:33051544, PMID:34262144]. PAK4 knockout in mice causes embryonic lethality with cardiac and neural developmental defects, and conditional neural deletion impairs progenitor proliferation and adherens junction formation, establishing PAK4 as essential for vertebrate development [PMID:14517283, PMID:21382368]."},"prefetch_data":{"uniprot":{"accession":"O96013","full_name":"Serine/threonine-protein kinase PAK 4","aliases":["p21-activated kinase 4","PAK-4"],"length_aa":591,"mass_kda":64.1,"function":"Serine/threonine-protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell adhesion turnover, cell migration, growth, proliferation or cell survival (PubMed:26598620). Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Promotes kinase-independent stabilization of RHOU, thereby contributing to focal adhesion disassembly during cell migration (PubMed:26598620)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O96013/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAK4","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000130669","cell_line_id":"CID001230","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"centrosome","grade":2},{"compartment":"cell_contact","grade":1}],"interactors":[{"gene":"YWHAE","stoichiometry":0.2},{"gene":"DYNC1H1","stoichiometry":0.2},{"gene":"RBM25","stoichiometry":0.2},{"gene":"SUB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001230","total_profiled":1310},"omim":[{"mim_id":"620426","title":"INKA BOX ACTIN REGULATOR 1; INKA1","url":"https://www.omim.org/entry/620426"},{"mim_id":"620403","title":"INKA-BOX ACTIN REGULATOR 2; INKA2","url":"https://www.omim.org/entry/620403"},{"mim_id":"620101","title":"RAS HOMOLOG FAMILY, MEMBER V; RHOV","url":"https://www.omim.org/entry/620101"},{"mim_id":"618441","title":"ADHESION G PROTEIN-COUPLED RECEPTOR G3; ADGRG3","url":"https://www.omim.org/entry/618441"},{"mim_id":"608110","title":"p21 PROTEIN-ACTIVATED KINASE 6; PAK6","url":"https://www.omim.org/entry/608110"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cell Junctions","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PAK4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O96013","domains":[{"cath_id":"3.30.200.20","chopping":"301-395","consensus_level":"high","plddt":93.5487,"start":301,"end":395},{"cath_id":"1.10.510.10","chopping":"400-588","consensus_level":"high","plddt":95.6746,"start":400,"end":588}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O96013","model_url":"https://alphafold.ebi.ac.uk/files/AF-O96013-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O96013-F1-predicted_aligned_error_v6.png","plddt_mean":70.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAK4","jax_strain_url":"https://www.jax.org/strain/search?query=PAK4"},"sequence":{"accession":"O96013","fasta_url":"https://rest.uniprot.org/uniprotkb/O96013.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O96013/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O96013"}},"corpus_meta":[{"pmid":"9822598","id":"PMC_9822598","title":"PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9822598","citation_count":309,"is_preprint":false},{"pmid":"11668177","id":"PMC_11668177","title":"Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11668177","citation_count":234,"is_preprint":false},{"pmid":"11278822","id":"PMC_11278822","title":"The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278822","citation_count":186,"is_preprint":false},{"pmid":"11313478","id":"PMC_11313478","title":"Activated PAK4 regulates cell adhesion and anchorage-independent growth.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11313478","citation_count":153,"is_preprint":false},{"pmid":"14517283","id":"PMC_14517283","title":"PAK4 kinase is essential for embryonic viability and for proper neuronal development.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14517283","citation_count":131,"is_preprint":false},{"pmid":"34368780","id":"PMC_34368780","title":"PAK4 inhibition improves PD-1 blockade immunotherapy.","date":"2019","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34368780","citation_count":126,"is_preprint":false},{"pmid":"27390344","id":"PMC_27390344","title":"Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.","date":"2016","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/27390344","citation_count":125,"is_preprint":false},{"pmid":"18424072","id":"PMC_18424072","title":"A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18424072","citation_count":123,"is_preprint":false},{"pmid":"22173096","id":"PMC_22173096","title":"Nucleo-cytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22173096","citation_count":121,"is_preprint":false},{"pmid":"35121889","id":"PMC_35121889","title":"Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma.","date":"2020","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35121889","citation_count":110,"is_preprint":false},{"pmid":"18836286","id":"PMC_18836286","title":"Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.","date":"2008","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18836286","citation_count":107,"is_preprint":false},{"pmid":"24829151","id":"PMC_24829151","title":"The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24829151","citation_count":98,"is_preprint":false},{"pmid":"17292838","id":"PMC_17292838","title":"Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs.","date":"2007","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/17292838","citation_count":97,"is_preprint":false},{"pmid":"14560027","id":"PMC_14560027","title":"Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14560027","citation_count":91,"is_preprint":false},{"pmid":"20406887","id":"PMC_20406887","title":"PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20406887","citation_count":89,"is_preprint":false},{"pmid":"23233484","id":"PMC_23233484","title":"Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.","date":"2012","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/23233484","citation_count":88,"is_preprint":false},{"pmid":"29858083","id":"PMC_29858083","title":"miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model.","date":"2018","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/29858083","citation_count":85,"is_preprint":false},{"pmid":"27919028","id":"PMC_27919028","title":"PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.","date":"2014","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/27919028","citation_count":84,"is_preprint":false},{"pmid":"16227624","id":"PMC_16227624","title":"PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16227624","citation_count":81,"is_preprint":false},{"pmid":"28062705","id":"PMC_28062705","title":"Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.","date":"2016","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28062705","citation_count":76,"is_preprint":false},{"pmid":"21385901","id":"PMC_21385901","title":"Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21385901","citation_count":76,"is_preprint":false},{"pmid":"23254288","id":"PMC_23254288","title":"Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/23254288","citation_count":72,"is_preprint":false},{"pmid":"30755582","id":"PMC_30755582","title":"PAK4 signaling in health and disease: defining the PAK4-CREB axis.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30755582","citation_count":70,"is_preprint":false},{"pmid":"22766504","id":"PMC_22766504","title":"MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22766504","citation_count":66,"is_preprint":false},{"pmid":"32977209","id":"PMC_32977209","title":"Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment.","date":"2020","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/32977209","citation_count":66,"is_preprint":false},{"pmid":"26546043","id":"PMC_26546043","title":"p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling.","date":"2015","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/26546043","citation_count":65,"is_preprint":false},{"pmid":"26598620","id":"PMC_26598620","title":"PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26598620","citation_count":61,"is_preprint":false},{"pmid":"28577975","id":"PMC_28577975","title":"Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28577975","citation_count":59,"is_preprint":false},{"pmid":"28198380","id":"PMC_28198380","title":"A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28198380","citation_count":58,"is_preprint":false},{"pmid":"21325635","id":"PMC_21325635","title":"Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.","date":"2011","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/21325635","citation_count":56,"is_preprint":false},{"pmid":"26607847","id":"PMC_26607847","title":"An in cellulo-derived structure of PAK4 in complex with its inhibitor Inka1.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26607847","citation_count":56,"is_preprint":false},{"pmid":"26841865","id":"PMC_26841865","title":"PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26841865","citation_count":56,"is_preprint":false},{"pmid":"20631255","id":"PMC_20631255","title":"Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20631255","citation_count":56,"is_preprint":false},{"pmid":"16897755","id":"PMC_16897755","title":"PAK4 and alphaPIX determine podosome size and number in macrophages through localized actin regulation.","date":"2006","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16897755","citation_count":55,"is_preprint":false},{"pmid":"29190083","id":"PMC_29190083","title":"Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors.","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29190083","citation_count":55,"is_preprint":false},{"pmid":"23893240","id":"PMC_23893240","title":"PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23893240","citation_count":55,"is_preprint":false},{"pmid":"23934187","id":"PMC_23934187","title":"Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23934187","citation_count":53,"is_preprint":false},{"pmid":"28542136","id":"PMC_28542136","title":"PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28542136","citation_count":52,"is_preprint":false},{"pmid":"26399456","id":"PMC_26399456","title":"MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.","date":"2015","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/26399456","citation_count":52,"is_preprint":false},{"pmid":"19594544","id":"PMC_19594544","title":"Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.","date":"2009","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/19594544","citation_count":51,"is_preprint":false},{"pmid":"26411419","id":"PMC_26411419","title":"PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.","date":"2015","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26411419","citation_count":51,"is_preprint":false},{"pmid":"34262144","id":"PMC_34262144","title":"CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34262144","citation_count":50,"is_preprint":false},{"pmid":"28534509","id":"PMC_28534509","title":"A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28534509","citation_count":46,"is_preprint":false},{"pmid":"34275493","id":"PMC_34275493","title":"Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model.","date":"2021","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/34275493","citation_count":45,"is_preprint":false},{"pmid":"23732710","id":"PMC_23732710","title":"The Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells.","date":"2013","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23732710","citation_count":43,"is_preprint":false},{"pmid":"23608596","id":"PMC_23608596","title":"Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics.","date":"2013","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/23608596","citation_count":43,"is_preprint":false},{"pmid":"30808546","id":"PMC_30808546","title":"A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30808546","citation_count":39,"is_preprint":false},{"pmid":"24945275","id":"PMC_24945275","title":"The serine-threonine protein kinase PAK4 is dispensable in zebrafish: identification of a morpholino-generated pseudophenotype.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24945275","citation_count":38,"is_preprint":false},{"pmid":"24130170","id":"PMC_24130170","title":"SH3RF2 functions as an oncogene by mediating PAK4 protein stability.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24130170","citation_count":38,"is_preprint":false},{"pmid":"28205613","id":"PMC_28205613","title":"PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28205613","citation_count":37,"is_preprint":false},{"pmid":"29304764","id":"PMC_29304764","title":"MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29304764","citation_count":37,"is_preprint":false},{"pmid":"30177834","id":"PMC_30177834","title":"A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30177834","citation_count":37,"is_preprint":false},{"pmid":"26297735","id":"PMC_26297735","title":"Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26297735","citation_count":36,"is_preprint":false},{"pmid":"18782768","id":"PMC_18782768","title":"MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18782768","citation_count":36,"is_preprint":false},{"pmid":"31728150","id":"PMC_31728150","title":"PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer.","date":"2019","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31728150","citation_count":35,"is_preprint":false},{"pmid":"22450748","id":"PMC_22450748","title":"P21-activated kinase 4 (PAK4) is required for metaphase spindle positioning and anchoring.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22450748","citation_count":34,"is_preprint":false},{"pmid":"23125951","id":"PMC_23125951","title":"PAK4-6 in cancer and neuronal development.","date":"2012","source":"Cellular logistics","url":"https://pubmed.ncbi.nlm.nih.gov/23125951","citation_count":33,"is_preprint":false},{"pmid":"29295922","id":"PMC_29295922","title":"CDC42 binds PAK4 via an extended GTPase-effector interface.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29295922","citation_count":32,"is_preprint":false},{"pmid":"33168646","id":"PMC_33168646","title":"Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33168646","citation_count":32,"is_preprint":false},{"pmid":"25672581","id":"PMC_25672581","title":"p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines.","date":"2014","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/25672581","citation_count":32,"is_preprint":false},{"pmid":"28641032","id":"PMC_28641032","title":"Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.","date":"2017","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/28641032","citation_count":32,"is_preprint":false},{"pmid":"30685413","id":"PMC_30685413","title":"miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30685413","citation_count":30,"is_preprint":false},{"pmid":"21382368","id":"PMC_21382368","title":"A key role for Pak4 in proliferation and differentiation of neural progenitor cells.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21382368","citation_count":30,"is_preprint":false},{"pmid":"30206161","id":"PMC_30206161","title":"Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia.","date":"2018","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/30206161","citation_count":30,"is_preprint":false},{"pmid":"35798086","id":"PMC_35798086","title":"PAK4 in cancer development: Emerging player and therapeutic opportunities.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/35798086","citation_count":29,"is_preprint":false},{"pmid":"30683654","id":"PMC_30683654","title":"PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30683654","citation_count":29,"is_preprint":false},{"pmid":"31905765","id":"PMC_31905765","title":"Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31905765","citation_count":28,"is_preprint":false},{"pmid":"31876149","id":"PMC_31876149","title":"KPT-9274, an Inhibitor of PAK4 and NAMPT, Leads to Downregulation of mTORC2 in Triple Negative Breast Cancer Cells.","date":"2020","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/31876149","citation_count":28,"is_preprint":false},{"pmid":"25410752","id":"PMC_25410752","title":"MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4).","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25410752","citation_count":26,"is_preprint":false},{"pmid":"31389670","id":"PMC_31389670","title":"Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31389670","citation_count":26,"is_preprint":false},{"pmid":"32231273","id":"PMC_32231273","title":"Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32231273","citation_count":25,"is_preprint":false},{"pmid":"27903866","id":"PMC_27903866","title":"Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson's disease.","date":"2016","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27903866","citation_count":25,"is_preprint":false},{"pmid":"27513084","id":"PMC_27513084","title":"Simvastatin Attenuates Acute Lung Injury via Regulating CDC42-PAK4 and Endothelial Microparticles.","date":"2017","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/27513084","citation_count":24,"is_preprint":false},{"pmid":"30520694","id":"PMC_30520694","title":"Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na+,K+-ATPase in pancreatic acinar cells.","date":"2018","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30520694","citation_count":23,"is_preprint":false},{"pmid":"31121213","id":"PMC_31121213","title":"PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/31121213","citation_count":23,"is_preprint":false},{"pmid":"32463132","id":"PMC_32463132","title":"Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.","date":"2020","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/32463132","citation_count":23,"is_preprint":false},{"pmid":"23326684","id":"PMC_23326684","title":"The pak4 protein kinase in breast cancer.","date":"2012","source":"ISRN oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23326684","citation_count":22,"is_preprint":false},{"pmid":"29100370","id":"PMC_29100370","title":"Identification of the PAK4 interactome reveals PAK4 phosphorylation of N-WASP and promotion of Arp2/3-dependent actin polymerization.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29100370","citation_count":22,"is_preprint":false},{"pmid":"22173944","id":"PMC_22173944","title":"Role for p21-activated kinase PAK4 in development of the mammalian heart.","date":"2011","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/22173944","citation_count":22,"is_preprint":false},{"pmid":"34246086","id":"PMC_34246086","title":"The role of PAK4 in the immune system and its potential implication in cancer immunotherapy.","date":"2021","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34246086","citation_count":21,"is_preprint":false},{"pmid":"25662318","id":"PMC_25662318","title":"Functional cross-talk between Cdc42 and two downstream targets, Par6B and PAK4.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25662318","citation_count":21,"is_preprint":false},{"pmid":"34973571","id":"PMC_34973571","title":"A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabine.","date":"2021","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34973571","citation_count":21,"is_preprint":false},{"pmid":"35755272","id":"PMC_35755272","title":"Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells.","date":"2022","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/35755272","citation_count":21,"is_preprint":false},{"pmid":"32606778","id":"PMC_32606778","title":"LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32606778","citation_count":21,"is_preprint":false},{"pmid":"39833606","id":"PMC_39833606","title":"Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/39833606","citation_count":20,"is_preprint":false},{"pmid":"32158195","id":"PMC_32158195","title":"Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways.","date":"2020","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32158195","citation_count":20,"is_preprint":false},{"pmid":"38810561","id":"PMC_38810561","title":"Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response.","date":"2024","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/38810561","citation_count":20,"is_preprint":false},{"pmid":"29048626","id":"PMC_29048626","title":"MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4.","date":"2017","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29048626","citation_count":20,"is_preprint":false},{"pmid":"29886323","id":"PMC_29886323","title":"Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors.","date":"2018","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29886323","citation_count":20,"is_preprint":false},{"pmid":"28502459","id":"PMC_28502459","title":"Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study.","date":"2017","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28502459","citation_count":20,"is_preprint":false},{"pmid":"25705811","id":"PMC_25705811","title":"Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.","date":"2015","source":"Organic & biomolecular chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25705811","citation_count":19,"is_preprint":false},{"pmid":"26821251","id":"PMC_26821251","title":"(-)-β-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26821251","citation_count":19,"is_preprint":false},{"pmid":"28284095","id":"PMC_28284095","title":"Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy.","date":"2017","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28284095","citation_count":19,"is_preprint":false},{"pmid":"32158221","id":"PMC_32158221","title":"Long Noncoding RNA SNHG7, a Molecular Sponge for microRNA-485, Promotes the Aggressive Behavior of Cervical Cancer by Regulating PAK4.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32158221","citation_count":19,"is_preprint":false},{"pmid":"20578242","id":"PMC_20578242","title":"N-terminal interaction domain implicates PAK4 in translational regulation and reveals novel cellular localization signals.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20578242","citation_count":18,"is_preprint":false},{"pmid":"33051544","id":"PMC_33051544","title":"PAK4 methylation by the methyltransferase SETD6 attenuates cell adhesion.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33051544","citation_count":17,"is_preprint":false},{"pmid":"26137045","id":"PMC_26137045","title":"microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells.","date":"2015","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/26137045","citation_count":17,"is_preprint":false},{"pmid":"27052178","id":"PMC_27052178","title":"Pak4 Is Required during Epithelial Polarity Remodeling through Regulating AJ Stability and Bazooka Retention at the ZA.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27052178","citation_count":16,"is_preprint":false},{"pmid":"34493720","id":"PMC_34493720","title":"Proximity proteomics identifies PAK4 as a component of Afadin-Nectin junctions.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34493720","citation_count":14,"is_preprint":false},{"pmid":"33615605","id":"PMC_33615605","title":"PAK4 suppresses motor neuron degeneration in hSOD1G93A -linked amyotrophic lateral sclerosis cell and rat models.","date":"2021","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/33615605","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47699,"output_tokens":9989,"usd":0.146466},"stage2":{"model":"claude-opus-4-6","input_tokens":14115,"output_tokens":5091,"usd":0.296775},"total_usd":0.443241,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"PAK4 was identified as a novel effector for Cdc42Hs, interacting only with the activated (GTP-bound) form through its GTPase-binding domain (GBD). Co-expression with constitutively active Cdc42HsV12 redistributes PAK4 to the Golgi membrane and induces filopodia and actin polymerization in a kinase activity-dependent manner.\",\n      \"method\": \"Co-expression, co-immunoprecipitation, dominant-negative/active mutants, immunofluorescence localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original discovery paper, multiple orthogonal methods, widely replicated\",\n      \"pmids\": [\"9822598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Serine 474 in the PAK4 kinase domain was identified as an autophosphorylation site in vivo; the S474E mutation confers constitutive kinase activation, and activated PAK4 (S474E) transforms NIH3T3 cells for anchorage-independent growth, while kinase-inactive PAK4 (K350A/K351A) blocks Ras-driven transformation.\",\n      \"method\": \"Phosphospecific antibody generation, site-directed mutagenesis, soft agar colony assay, co-expression with activated Cdc42\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo phosphorylation mapping with mutagenesis and functional validation\",\n      \"pmids\": [\"11668177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PAK4 protects cells from apoptosis by phosphorylating the proapoptotic protein Bad, leading to inhibition of caspase activation. Expression of wild-type or constitutively active PAK4 delays apoptosis induced by TNF-α, UV irradiation, and serum starvation.\",\n      \"method\": \"Overexpression of wild-type and constitutively active PAK4 mutants, phosphorylation assay of Bad, caspase activation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple stimuli tested, direct substrate phosphorylation demonstrated, replicated in subsequent studies\",\n      \"pmids\": [\"11278822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Constitutively active PAK4 dissolves actin stress fibers and focal adhesions, impairs cell spreading on fibronectin, and induces anchorage-independent growth in fibroblasts. Dominant-negative PAK4 inhibits Dbl-induced focus formation, placing PAK4 downstream of Rho GTPase exchange factors in oncogenic transformation.\",\n      \"method\": \"Expression of activated/dominant-negative PAK4 mutants, soft agar assay, focus formation assay, immunofluorescence\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with dominant-negative mutants, multiple cellular readouts, replicated\",\n      \"pmids\": [\"11313478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PAK4 knockout in mice causes embryonic lethality by E11.5 with defects in fetal heart development and spinal cord motor neuron/interneuron differentiation and migration, establishing PAK4 as essential for neuronal development and cytoskeletal organization in vivo.\",\n      \"method\": \"Gene knockout (homologous recombination), histological analysis, phenotypic characterization of PAK4-null embryos\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with specific developmental phenotypes\",\n      \"pmids\": [\"14517283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PAK4 inhibits death receptor-induced apoptosis by antagonizing initiator caspase 8 activation, independent of PAK4 kinase activity, potentially by blocking caspase 8 recruitment to death domain receptors (TNF-R, Fas).\",\n      \"method\": \"Overexpression of kinase-active and kinase-dead PAK4, caspase 8 activity assay, apoptosis assay with TNF-α/Fas stimulation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — kinase-independent mechanism defined by mutagenesis, single lab\",\n      \"pmids\": [\"14560027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Endogenous PAK4 is required for optimal TRADD binding to the activated TNF-α receptor through both kinase-dependent and kinase-independent mechanisms, thereby enabling full activation of NF-κB and ERK pro-survival pathways downstream of TNF-α.\",\n      \"method\": \"RNAi knockdown of endogenous PAK4, co-immunoprecipitation of TRADD with TNF-R, NF-κB and ERK pathway assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — endogenous knockdown with specific Co-IP readout, single lab\",\n      \"pmids\": [\"16227624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAK4 and alphaPIX regulate podosome size and number in primary human macrophages; kinase-active PAK4 increases podosome size while kinase-inactive PAK4 decreases it, demonstrating kinase activity-dependent regulation of localized actin dynamics at podosomes.\",\n      \"method\": \"Immunofluorescence, shRNA knockdown, transfection of kinase-active/-inactive PAK4 mutants, microarray\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — primary cell system, kinase mutant analysis, single lab\",\n      \"pmids\": [\"16897755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structures of active, monophosphorylated PAK4 catalytic domain (along with PAK5 and PAK6) revealed domain plasticity including rearrangements of helix αC with an additional helical turn, forming interactions that link the glycine-rich loop, αC, and the activation segment to anchor αC in an active conformation. A tri-substituted purine inhibitor was co-crystallized with PAK4.\",\n      \"method\": \"X-ray crystallography (multiple high-resolution structures), inhibitor co-crystallization\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple crystal structures with functional interpretation and inhibitor co-crystal\",\n      \"pmids\": [\"17292838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PAK4 binds to and phosphorylates LIMK1 in an HGF-dependent manner in prostate cancer cells, altering cofilin phosphorylation levels, cell morphology, and migration speed. PAK4 and LIMK1 interact in small foci at the cell periphery as confirmed by FRET-FLIM.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, FRET-FLIM, siRNA knockdown, cell migration assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation shown, FRET-FLIM localization, multiple methods\",\n      \"pmids\": [\"18424072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The PAK4-JNK signaling pathway acts as a negative regulator of Streptococcus pneumoniae pneumolysin-induced MUC5AC mucin transcription; MKP1 inhibits this PAK4-JNK pathway (induced via TLR4-MyD88-TRAF6-ERK) to upregulate MUC5AC production.\",\n      \"method\": \"Signaling pathway inhibitor studies, mucosal epithelial cell assays, MUC5AC transcription reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway epistasis defined, single lab\",\n      \"pmids\": [\"18782768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PAK4 localizes at focal adhesions, co-immunoprecipitates with paxillin, and directly phosphorylates paxillin on serine 272, regulating focal adhesion turnover and cell migration in prostate cancer cells. PAK4 also regulates RhoA activity via GEF-H1.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, immunofluorescence localization, siRNA knockdown, cell migration assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct substrate phosphorylation, localization, and functional validation\",\n      \"pmids\": [\"20406887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Cdc42-dependent recruitment of PAK4 to nascent cell-cell contacts is required for the maturation of primordial junctions into apical junctions in human bronchial epithelial cells; PAK4 kinase activity is essential for junction maturation, and Par6B/aPKC retains PAK4 at junction sites.\",\n      \"method\": \"siRNA library screen of 36 Cdc42 targets, immunofluorescence, dominant-active PAK4 overexpression\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic siRNA screen, kinase mutant validation, multiple cellular readouts\",\n      \"pmids\": [\"20631255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CDK5RAP3 is a novel binding partner of PAK4 that enhances PAK4 kinase activity; PAK4 knockdown in CDK5RAP3-overexpressing HCC cells reverses CDK5RAP3-mediated enhanced invasiveness, placing PAK4 as an essential downstream effector of CDK5RAP3.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, in vitro kinase assay, invasion assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction and kinase activation demonstrated, single lab\",\n      \"pmids\": [\"21385901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PAK4 is a nucleo-cytoplasmic shuttling protein containing three nuclear export signals (NESs) and two nuclear localization signals (NLSs); it is exported via CRM-1-dependent pathway and imported via importin α5. Nuclear PAK4 phosphorylates β-catenin on Ser675, stabilizes β-catenin, promotes TCF/LEF transcriptional activity, and associates with the TCF/LEF transcriptional complex at chromatin.\",\n      \"method\": \"Deletion mutant analysis, nuclear/cytoplasmic fractionation, co-immunoprecipitation, phosphorylation assay, ChIP, luciferase reporter assay\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including ChIP and in vitro phosphorylation\",\n      \"pmids\": [\"22173096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Conditional nervous system-specific knockout of Pak4 (nestin-Cre) causes reduced proliferation and self-renewal of cortical and striatal neural progenitor cells, cortical thinning, impaired neurogenesis, and loss of neuroepithelial adherens junctions, establishing PAK4 as essential for neural progenitor cell proliferation and brain development.\",\n      \"method\": \"Conditional knockout (Cre-lox), BrdU proliferation assay, neurosphere culture, histological analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional genetic knockout with defined cellular phenotypes\",\n      \"pmids\": [\"21382368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Conditional deletion of PAK4 in secondary heart field progenitors causes abnormal outflow tract development and cardiomyocytes depleted of PAK4 show reduced LIMK1 levels and severely compromised sarcomeric structure, placing PAK4 upstream of LIMK1 in cardiac cytoskeletal organization.\",\n      \"method\": \"Conditional knockout, histological/echocardiographic analysis, PAK4 knockdown in cultured cardiomyocytes, LIMK1 western blot\",\n      \"journal\": \"Transgenic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional knockout with molecular readout (LIMK1), single lab\",\n      \"pmids\": [\"22173944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PAK4 directly interacts with MMP-2 through its kinase domain (demonstrated by GST pull-down), and PAK4 regulates αvβ3-integrin and phospho-EGFR survival signaling in glioma cells; dual PAK4/MMP-2 depletion causes robust anoikis-mediated cell death.\",\n      \"method\": \"GST pull-down, siRNA knockdown, anoikis assay, cDNA-PCR arrays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct interaction by pull-down, functional epistasis, single lab\",\n      \"pmids\": [\"23254288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PAK4 depletion results in defective astral microtubule networks, failure of spindle centering, and prolonged metaphase-like state with chromosome scattering; PAK4 regulates dynein/dynactin complex localization at kinetochores and on astral microtubules, establishing PAK4 as required for metaphase spindle positioning and anchoring.\",\n      \"method\": \"siRNA knockdown, live cell imaging, immunofluorescence, spindle orientation analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean depletion with specific mechanistic readout (dynein/dynactin), single lab\",\n      \"pmids\": [\"22450748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PAK4 interacts with Smad2/3 via a kinase-independent mechanism that blocks TGF-β1-induced phosphorylation of Smad2 Ser465/467 and Smad3 Ser423/425. Additionally, PAK4 phosphorylates Smad2 on Ser465, leading to its ubiquitin-proteasome-dependent degradation under HGF stimulation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, ubiquitination assay, kinase-inactive mutant analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation and ubiquitin-mediated degradation demonstrated with multiple methods\",\n      \"pmids\": [\"23934187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PAK4 kinase phosphorylates SCG10 (stathmin-2) on serine 50, regulating microtubule dynamics to promote gastric cancer cell migration and invasion; inhibition of PAK4 by LCH-7749944 or RNAi blocks Ser50 phosphorylation and cell invasion.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, phospho-specific antibody, xenograft mouse model, siRNA knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct substrate phosphorylation with mutagenesis and in vivo validation\",\n      \"pmids\": [\"23893240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SH3RF2 binds PAK4 and inhibits its ubiquitin-proteasome-dependent degradation through steric hindrance, stabilizing PAK4 protein levels. Loss of SH3RF2 reduces TRADD recruitment to TNF-R1 and impairs NF-κB signaling, consistent with PAK4 stabilization being required for these downstream effects.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment, siRNA knockdown\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction and ubiquitination suppression demonstrated, single lab\",\n      \"pmids\": [\"24130170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NDRG1 reduces nuclear localization of PAK4, thereby inhibiting PAK4-dependent nuclear translocation of β-catenin and downstream TCF/LEF transcriptional activity; this defines a NDRG1→PAK4→β-catenin nuclear transport axis.\",\n      \"method\": \"Nuclear/cytoplasmic fractionation, Co-immunoprecipitation, reporter assay, immunofluorescence\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway placement, multiple methods, single lab\",\n      \"pmids\": [\"24829151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAK4 phosphorylates Par6B at Ser143, blocking Par6B's interaction with Cdc42, providing a feedback mechanism to control Par6B subcellular localization and polarity complex formation in apical junction assembly.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, co-immunoprecipitation, immunofluorescence\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation with mutagenesis, single lab\",\n      \"pmids\": [\"25662318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAK4 stabilizes RhoU protein in a kinase-independent manner by protecting it from ubiquitination by the Rab40A-Cullin 5 E3 ligase complex; RhoU overexpression rescues the PAK4 depletion adhesion-turnover phenotype, defining a kinase-independent scaffolding function of PAK4.\",\n      \"method\": \"siRNA depletion, ubiquitination assay, RhoU rescue experiment, co-immunoprecipitation, cell adhesion/migration assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway defined with rescue experiment and ubiquitination assay, multiple methods\",\n      \"pmids\": [\"26598620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In cellulo crystal structure of human PAK4 catalytic domain in complex with its endogenous inhibitor Inka1 was determined at 2.95 Å resolution, revealing how the PAK4 catalytic domain binds cellular ATP and Inka1. The PAK4-PAK4 lattice forms a hexagonal array accommodating other proteins fused to Inka1.\",\n      \"method\": \"In cellulo X-ray crystallography, live-cell crystal imaging with Inka1-GFP\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in cellulo crystal structure at 2.95 Å with functional inhibitor complex\",\n      \"pmids\": [\"26607847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Integrin αvβ3 recruits and activates PAK4 to counteract senescence in glioblastoma cells; targeting either αvβ3 or PAK4 leads to p21-dependent, p53-independent cell senescence, establishing an αvβ3→PAK4 axis that enables glioblastoma cells to evade oncogene-induced senescence.\",\n      \"method\": \"RNAi knockdown, genetic deletion, senescence assay (SA-β-galactosidase), p21/p53 analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis defined by dual knockdown, specific senescence phenotype, single lab\",\n      \"pmids\": [\"26297735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SETD6 methyltransferase methylates PAK4 both in vitro and at chromatin in cells; SETD6 methylation of PAK4 dramatically increases the PAK4-β-catenin physical interaction and promotes transcription of Wnt/β-catenin target genes.\",\n      \"method\": \"In vitro methylation assay, co-immunoprecipitation, luciferase reporter assay, ChIP, siRNA depletion of SETD6\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro and in cellulo methylation demonstrated, chromatin association shown, multiple methods\",\n      \"pmids\": [\"26841865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drosophila Pak4/Mbt phosphorylates β-catenin/Armadillo to regulate AJ morphogenesis and stability during zonula adherens remodeling; this β-catenin phosphorylation is required for retention of Par3/Bazooka at the remodeling ZA and cooperates with Par1-dependent lateral exclusion to regulate apical membrane differentiation.\",\n      \"method\": \"Conditional genetics, phosphorylation assay, immunofluorescence in Drosophila epithelium, AJ morphogenesis assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct substrate phosphorylation in a genetic model, replicated by structure in mammalian system\",\n      \"pmids\": [\"27052178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PAK4 promotes neuroprotection of dopaminergic neurons by phosphorylating CRTC1 (CREB-regulated transcription coactivator) at S215; non-phosphorylatable CRTC1-S215A abolishes the ability of constitutively active PAK4 to induce Bcl-2, BDNF, and PGC-1α expression through CREB, defining a PAK4→CRTC1-S215→CREB neuroprotective axis.\",\n      \"method\": \"Constitutively active PAK4 expression, site-directed mutagenesis of CRTC1, viral delivery in rat PD models, Western blot for CREB targets\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct substrate phosphorylation with mutagenesis and in vivo validation in rat models\",\n      \"pmids\": [\"27903866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PAK4 phosphorylates N-WASP at Ser484/Ser485 and promotes Arp2/3-dependent actin polymerization in vitro; PAK4 ablation reduces N-WASP phosphorylation and alters the G-actin/F-actin balance and actin organization in cells. The PAK4 interactome (by iTRAQ mass spectrometry) is enriched in 14-3-3, proteasome, replication fork, CCT, and Arp2/3 complexes.\",\n      \"method\": \"iTRAQ quantitative MS of PAK4 immunoprecipitations, in vitro kinase assay, in vitro actin polymerization assay, PAK4 ablation\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro actin polymerization, direct phosphorylation site identified, systematic interactome\",\n      \"pmids\": [\"29100370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PAK4 regulates G6PD activity and cellular pentose phosphate pathway flux by enhancing Mdm2-mediated ubiquitination and degradation of p53, thereby promoting glucose uptake, NADPH production, and lipid biosynthesis in colon cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, G6PD activity assay, metabolic flux analysis, siRNA knockdown\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway defined with enzymatic and ubiquitination assays, single lab\",\n      \"pmids\": [\"28542136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PAK4 interacts with the p85α regulatory subunit of PI3K; PAK4-deficient pancreatic cancer cells show reduced Akt phosphorylation downstream of HGF signaling, implicating PAK4 within the PI3K/Akt pathway via p85α.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, Western blot for p-Akt, HGF-stimulated migration assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with functional correlation, single lab\",\n      \"pmids\": [\"28205613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Zic2 transcription factor directly binds the PAK4 promoter and activates PAK4 transcription (shown by ChIP and luciferase assay); PAK4 mediates Zic2-driven HCC cell growth via the Raf/MEK/ERK pathway.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, siRNA knockdown epistasis, MEK/ERK pathway inhibition\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding confirmed by ChIP and reporter, pathway epistasis, single lab\",\n      \"pmids\": [\"28577975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure and solution scattering of full-length PAK4 in complex with CDC42 revealed that beyond the canonical CRIB domain interaction, the PAK4 kinase C-lobe and polybasic region also contact CDC42, increasing binding affinity for full-length PAK4 and modulating kinase activity.\",\n      \"method\": \"X-ray crystallography, small-angle X-ray scattering (SAXS), kinase activity assay, binding affinity measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation of extended interface\",\n      \"pmids\": [\"29295922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAK4 phosphorylates CEBPB on Thr-235, which activates CEBPB-mediated transcription of claudin-4 (CLDN4), promoting breast cancer cell migration and invasion in a PAK4-CEBPB-CLDN4 axis.\",\n      \"method\": \"siRNA knockdown, luciferase reporter assay (CLDN4 promoter), Western blot for p-CEBPB, rescue experiments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — phosphorylation site and transcriptional axis defined, single lab\",\n      \"pmids\": [\"30808546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Nuclear PAK4 (nPAK4) co-translocates with ERα from cytoplasm to nucleus upon 17β-estradiol stimulation, represses ERα-mediated transactivation, and promotes bone metastasis of ER+ breast cancer cells by targeting LIFR (a bone metastasis suppressor) through a PAK4-ERα nuclear axis.\",\n      \"method\": \"Nuclear/cytoplasmic fractionation, co-immunoprecipitation, ChIP, luciferase reporter, in vivo metastasis model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — nuclear co-translocation and chromatin association demonstrated, single lab\",\n      \"pmids\": [\"30177834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAK4 phosphorylates fumarase (FH) at Ser46, causing FH to bind 14-3-3 protein and become sequestered in the cytosol, thereby preventing formation of the FH/CSL/p53 nuclear complex that drives p21 transcription and TGF-β-induced cell growth arrest in lung cancer cells.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, co-immunoprecipitation, ChIP, cell growth arrest assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation with mutagenesis, 14-3-3 binding, and nuclear complex formation shown\",\n      \"pmids\": [\"30683654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAK4 phosphorylates CRTC1 at S215 to activate CREB signaling and protect motor neurons from degeneration; the PAK4/CREB pathway is inhibited in ALS models and PAK4 overexpression in spinal neurons of hSOD1G93A rats suppresses motor neuron degeneration and prolongs survival.\",\n      \"method\": \"Constitutively active PAK4 overexpression, CREB inhibitor experiments, in vivo spinal injection, rotarod motor function test, apoptosis assay\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo rescue with defined molecular pathway, single lab\",\n      \"pmids\": [\"33615605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SETD6-mediated methylation of PAK4 at lysine 473 (K473) activates β-catenin transcriptional activity and inhibits cell adhesion by reducing paxillin localization to focal adhesions, decreasing filopodia, actin structures, and cell migration/invasion.\",\n      \"method\": \"Site-directed mutagenesis (K473 methylation site), immunofluorescence of focal adhesions/paxillin, β-catenin reporter assay, cell adhesion assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — specific methylation site identified with mutagenesis, multiple downstream readouts\",\n      \"pmids\": [\"33051544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PAK4 reprograms glioblastoma tumor endothelial cells through a MEF2D/ZEB1- and SLUG-mediated mechanism that downregulates claudin-14 and VCAM-1 expression, enhancing vessel permeability and reducing T cell adhesion to the endothelium; PAK4 knockout in ECs reduces vascular abnormalities and improves T cell infiltration.\",\n      \"method\": \"PAK4 knockout in ECs, transcriptome analysis, ChIP for MEF2D/ZEB1/SLUG at claudin-14 and VCAM-1 promoters, T cell adhesion assay, in vivo tumor models\",\n      \"journal\": \"Nature cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout, transcriptomic profiling, ChIP mechanistic validation, in vivo\",\n      \"pmids\": [\"35121889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CDK15 binds PAK4 and phosphorylates it at Ser291, promoting colorectal cancer cell proliferation and anchorage-independent growth through β-catenin/c-Myc and MEK/ERK signaling pathways; PAK4 inhibition reverses CDK15-driven tumorigenesis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis (S291), CDK15 knockout in mice (AOM/DSS model), PDX model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation site identified with in vitro assay, mutagenesis, and in vivo validation\",\n      \"pmids\": [\"34262144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BioID proximity proteomics revealed that PAK4 is enriched at Afadin/Nectin junctions; PAK4 depends on Afadin for junctional localization. Phosphoproteomics after PAK4 inhibitor treatment identified 17 PAK4 phosphorylation sites on junctional proteins, defining PAK4 as selective for the Afadin/nectin sub-compartment.\",\n      \"method\": \"BioID proximity labeling, quantitative mass spectrometry, co-immunoprecipitation, phosphoproteomics with PAK4 inhibitors, immunofluorescence\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — systematic proximity proteomics, phosphoproteomics, and localization studies\",\n      \"pmids\": [\"34493720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PAK4 N-terminal domain associates with ribonucleoprotein (RNP) complexes and active PAK4 can affect cap-independent (IRES-mediated) translation in vivo; the N-terminal domain also contains nuclear export signals and cytoplasmic targeting elements, with endogenous PAK4 found in both cytoplasmic and nuclear fractions.\",\n      \"method\": \"Affinity chromatography, co-immunoprecipitation with RNP components, IRES-mediated translation reporter assay, subcellular fractionation\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — novel function shown by direct binding and functional reporter, single lab\",\n      \"pmids\": [\"20578242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"VIP and secretin activate PAK4 in pancreatic acinar cells via cAMP pathways (VIP via EPAC; secretin via PKA), and PAK4 activation is required for subsequent Na+,K+-ATPase activation and pancreatic fluid secretion.\",\n      \"method\": \"Selective cAMP pathway inhibitors (KT-5720, PKI, ESI-09, HJC0197), PAK4 inhibitors (PF-3758309, LCH-7749944), PAK4 kinase activity assay, Na+,K+-ATPase activity assay\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with multiple inhibitors, functional readout\",\n      \"pmids\": [\"30520694\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAK4 is a Cdc42-activated serine/threonine kinase that signals downstream of Rho-family GTPases to regulate actin cytoskeletal organization (via LIMK1/cofilin, N-WASP/Arp2/3, paxillin, and RhoU stabilization), cell survival (phosphorylating Bad and CRTC1/CREB, antagonizing caspase 8), Wnt/β-catenin transcription (phosphorylating β-catenin at Ser675 and undergoing SETD6-mediated lysine methylation that further enhances β-catenin interaction), and cell proliferation/transformation; its activity is modulated by CDK15-mediated phosphorylation at Ser291 and SETD6-mediated methylation at K473, and it functions both as a kinase and as a kinase-independent scaffold (stabilizing RhoU from Rab40A-Cullin5-mediated ubiquitination) with localization to Golgi, focal adhesions, cell-cell junctions (particularly the Afadin/nectin compartment), and the nucleus.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PAK4 is a Cdc42-activated serine/threonine kinase that functions as a central integrator of cytoskeletal remodeling, cell survival, cell polarity, and transcriptional regulation downstream of Rho-family GTPases. Upon binding GTP-loaded Cdc42, PAK4 autophosphorylates at Ser474 to become catalytically active and phosphorylates diverse substrates including LIMK1 and N-WASP (driving Arp2/3-dependent actin polymerization), paxillin (regulating focal adhesion turnover), β-catenin at Ser675 (promoting Wnt/TCF/LEF transcription), Bad (inhibiting apoptosis), CRTC1 at Ser215 (activating CREB-dependent neuroprotective gene expression), and Smad2 (triggering its degradation to antagonize TGF-β signaling) [PMID:9822598, PMID:11668177, PMID:18424072, PMID:20406887, PMID:22173096, PMID:27903866, PMID:23934187, PMID:29100370]. PAK4 also operates through kinase-independent scaffolding, notably stabilizing RhoU by shielding it from Rab40A-Cullin5-mediated ubiquitination and antagonizing caspase-8 activation at death receptors [PMID:26598620, PMID:14560027]. Its activity is modulated by SETD6-mediated lysine methylation at K473, which enhances β-catenin interaction and Wnt target gene transcription while reducing focal adhesion integrity, and by CDK15-mediated phosphorylation at Ser291, which promotes β-catenin/c-Myc and MEK/ERK signaling [PMID:26841865, PMID:33051544, PMID:34262144]. PAK4 knockout in mice causes embryonic lethality with cardiac and neural developmental defects, and conditional neural deletion impairs progenitor proliferation and adherens junction formation, establishing PAK4 as essential for vertebrate development [PMID:14517283, PMID:21382368].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The identification of PAK4 as a novel Cdc42 effector that localizes to the Golgi and induces filopodia established that a distinct group II PAK kinase links Rho-family GTPase signaling to actin cytoskeletal remodeling.\",\n      \"evidence\": \"Co-immunoprecipitation of PAK4 with GTP-bound Cdc42, immunofluorescence showing Golgi relocalization and filopodia induction in transfected cells\",\n      \"pmids\": [\"9822598\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrates mediating actin remodeling were unknown\", \"Physiological activation context beyond overexpression was undefined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapping the Ser474 autophosphorylation site as the activating event, and demonstrating that constitutively active PAK4 transforms fibroblasts while kinase-dead PAK4 blocks Ras transformation, established PAK4 as an oncogenic kinase and defined its activation mechanism.\",\n      \"evidence\": \"Phosphospecific antibody, S474E constitutive activation mutant, soft agar colony formation and focus formation assays\",\n      \"pmids\": [\"11668177\", \"11313478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals triggering Ser474 autophosphorylation in vivo were unclear\", \"Direct transformation targets were unidentified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that PAK4 phosphorylates Bad and inhibits caspase activation provided the first direct survival substrate, while a subsequent study showed kinase-independent caspase-8 antagonism, revealing dual mechanisms for anti-apoptotic function.\",\n      \"evidence\": \"Bad phosphorylation assay, caspase activity assays under TNF-α/UV/serum deprivation, kinase-dead mutant retaining caspase-8 inhibition\",\n      \"pmids\": [\"11278822\", \"14560027\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The precise kinase-independent mechanism for caspase-8 inhibition was not structurally resolved\", \"Whether Bad phosphorylation is direct in endogenous settings was not confirmed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"PAK4 knockout embryonic lethality with cardiac and neural defects proved that PAK4 is non-redundant with other PAK family members for vertebrate development, particularly for heart and spinal cord morphogenesis.\",\n      \"evidence\": \"Homologous recombination knockout, histological analysis of E11.5 embryos\",\n      \"pmids\": [\"14517283\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which PAK4 substrates mediate the cardiac versus neuronal phenotypes was unknown\", \"Conditional tissue-specific requirements had not yet been dissected\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing that endogenous PAK4 promotes TRADD recruitment to TNF-R1 and activates NF-κB/ERK pathways placed PAK4 as an upstream organizer of TNF receptor signaling complexes, not merely an anti-apoptotic effector.\",\n      \"evidence\": \"RNAi knockdown of endogenous PAK4, TRADD co-immunoprecipitation with TNF-R, NF-κB and ERK assays\",\n      \"pmids\": [\"16227624\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PAK4 directly phosphorylates TRADD or a scaffold component was not determined\", \"Single-lab finding without independent replication\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Crystal structures of the active PAK4 catalytic domain revealed the structural basis for group II PAK activation, including αC helix rearrangements that distinguish it from group I PAKs, and enabled structure-based inhibitor design.\",\n      \"evidence\": \"Multiple X-ray crystal structures including inhibitor co-crystal\",\n      \"pmids\": [\"17292838\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length PAK4 structure with autoinhibitory domain was not resolved\", \"How Cdc42 binding allosterically activates the kinase domain was structurally undefined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of LIMK1 as a direct PAK4 substrate linking HGF signaling to cofilin phosphorylation and cell migration established the PAK4→LIMK1→cofilin pathway as a core actin regulatory axis.\",\n      \"evidence\": \"In vitro kinase assay, FRET-FLIM co-localization at cell periphery, siRNA and migration assays in prostate cancer cells\",\n      \"pmids\": [\"18424072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific LIMK1 phosphorylation site(s) by PAK4 were not mapped\", \"Whether this pathway operates in non-cancer contexts was untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that PAK4 phosphorylates paxillin at Ser272 at focal adhesions and is recruited to cell-cell junctions via Cdc42 for junction maturation expanded PAK4's role from actin dynamics to adhesion-dependent signaling at two distinct subcellular compartments.\",\n      \"evidence\": \"In vitro kinase assay and immunofluorescence for paxillin; siRNA screen of 36 Cdc42 targets for junction maturation in bronchial epithelial cells\",\n      \"pmids\": [\"20406887\", \"20631255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PAK4 is differentially targeted to focal adhesions versus junctions was unclear\", \"The junctional substrates downstream of PAK4 at cell-cell contacts were unidentified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that PAK4 shuttles between nucleus and cytoplasm via CRM1/importin-α5 and phosphorylates nuclear β-catenin at Ser675 to activate TCF/LEF transcription established a direct role for PAK4 in Wnt pathway transcriptional output.\",\n      \"evidence\": \"Deletion mutant mapping of NLS/NES, nuclear fractionation, ChIP showing PAK4 at TCF/LEF-bound chromatin, β-catenin Ser675 phosphorylation assay\",\n      \"pmids\": [\"22173096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which Wnt ligands activate this nuclear PAK4 pool was unknown\", \"Whether nuclear PAK4 kinase activity is regulated differently from cytoplasmic activity was not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Conditional neural knockout revealed that PAK4 is essential for cortical progenitor proliferation, neurosphere self-renewal, and adherens junction maintenance, connecting its junctional and cytoskeletal functions to brain development.\",\n      \"evidence\": \"Nestin-Cre conditional knockout, BrdU proliferation assay, neurosphere culture, histological analysis\",\n      \"pmids\": [\"21382368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream substrates responsible for neural progenitor proliferation were not identified\", \"Whether cardiac-specific conditional knockout phenocopies the global knockout heart defect was only partially addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of Smad2/3 as PAK4 substrates and interactors, with PAK4 phosphorylation triggering Smad2 ubiquitin-dependent degradation, revealed a mechanism by which HGF/PAK4 antagonizes TGF-β tumor-suppressive signaling.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase assay, ubiquitination assay with kinase-dead controls\",\n      \"pmids\": [\"23934187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ligase mediating Smad2 degradation downstream of PAK4 was not identified\", \"In vivo relevance in tumor models was not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that PAK4 stabilizes RhoU by preventing Rab40A-Cullin5-mediated ubiquitination, and that RhoU rescues PAK4 depletion adhesion phenotypes, established a kinase-independent scaffolding function distinct from PAK4's catalytic roles.\",\n      \"evidence\": \"Ubiquitination assay, RhoU rescue of PAK4-depleted cells, co-immunoprecipitation\",\n      \"pmids\": [\"26598620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how PAK4 shields RhoU from the E3 ligase was unknown\", \"Whether other substrates of Rab40A-Cullin5 are similarly protected was not investigated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"SETD6-mediated methylation of PAK4 at K473 was shown to enhance β-catenin binding and Wnt target transcription, establishing lysine methylation as a post-translational regulatory layer on PAK4 that modulates its transcriptional functions and adhesion properties.\",\n      \"evidence\": \"In vitro methylation assay, ChIP for PAK4/β-catenin at Wnt target promoters, focal adhesion and migration assays with K473 mutants\",\n      \"pmids\": [\"26841865\", \"33051544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conditions under which SETD6 methylates PAK4 physiologically were not defined\", \"Whether demethylases reverse this modification was unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of CRTC1-Ser215 as a PAK4 substrate that activates CREB-dependent expression of Bcl-2, BDNF, and PGC-1α in dopaminergic neurons defined a PAK4→CRTC1→CREB neuroprotective signaling axis with therapeutic implications for neurodegeneration.\",\n      \"evidence\": \"Site-directed mutagenesis of CRTC1 S215, viral delivery of constitutively active PAK4 in rat Parkinson's disease models, Western blot for CREB targets\",\n      \"pmids\": [\"27903866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous upstream activators of PAK4 in neurons were not defined\", \"Long-term neuroprotective efficacy was not assessed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"N-WASP phosphorylation at Ser484/485 by PAK4, promoting Arp2/3-dependent actin polymerization in vitro, and a systematic PAK4 interactome enriched in actin regulators, proteasome, and replication fork components, broadened the substrate repertoire and pointed to additional PAK4 functions.\",\n      \"evidence\": \"In vitro kinase assay, reconstituted actin polymerization assay, iTRAQ quantitative mass spectrometry of PAK4 immunoprecipitates\",\n      \"pmids\": [\"29100370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Many interactome hits (replication fork, CCT) were not functionally validated\", \"In vivo relevance of N-WASP Ser484/485 phosphorylation was not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The crystal structure of full-length PAK4 in complex with CDC42 revealed additional contacts beyond the CRIB domain — involving the kinase C-lobe and polybasic region — explaining higher affinity of full-length PAK4 for Cdc42 and resolving how GTPase binding modulates kinase activity.\",\n      \"evidence\": \"X-ray crystallography, SAXS, binding affinity measurements, kinase assays\",\n      \"pmids\": [\"29295922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the autoinhibitory domain is released upon Cdc42 binding at a conformational dynamics level was not captured\", \"Structures with downstream substrates bound were not obtained\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"PAK4 phosphorylation of fumarase at Ser46 sequesters it in the cytoplasm via 14-3-3 binding, preventing nuclear FH/CSL/p53-driven p21 transcription, revealing a mechanism by which PAK4 overrides metabolic tumor-suppressive checkpoints.\",\n      \"evidence\": \"In vitro kinase assay, S46A mutagenesis, 14-3-3 co-immunoprecipitation, ChIP for nuclear FH complex\",\n      \"pmids\": [\"30683654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this mechanism operates in normal non-cancer physiology was not tested\", \"The quantitative contribution of FH phosphorylation to overall PAK4 oncogenicity was not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that PAK4 reprograms tumor endothelial cells via MEF2D/ZEB1/SLUG-mediated downregulation of claudin-14 and VCAM-1, impairing T cell adhesion and infiltration, established PAK4 as a cell-non-autonomous regulator of anti-tumor immunity.\",\n      \"evidence\": \"PAK4 knockout in endothelial cells, transcriptome analysis, ChIP for MEF2D/ZEB1/SLUG at target promoters, T cell adhesion assay, in vivo glioblastoma models\",\n      \"pmids\": [\"35121889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PAK4 directly phosphorylates MEF2D or acts indirectly was not resolved\", \"Relevance to non-brain tumor vasculature was not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CDK15 was identified as an upstream kinase phosphorylating PAK4 at Ser291 to drive β-catenin/c-Myc and MEK/ERK signaling in colorectal cancer, and BioID proximity proteomics placed PAK4 specifically at the Afadin/nectin junctional sub-compartment with 17 junctional phosphosubstrates.\",\n      \"evidence\": \"CDK15 in vitro kinase assay with S291 mutagenesis, AOM/DSS mouse model, PDX model; BioID proximity labeling, quantitative phosphoproteomics with PAK4 inhibitors\",\n      \"pmids\": [\"34262144\", \"34493720\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CDK15-mediated Ser291 phosphorylation changes PAK4 structure or substrate selectivity was unknown\", \"Functional validation of the 17 junctional phosphosites was incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanisms by which PAK4 selectively partitions between its junctional, focal adhesion, nuclear, and Golgi pools, and how post-translational modifications (K473 methylation, S291 phosphorylation, S474 autophosphorylation) coordinately tune substrate selectivity in each compartment, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No integrated model of compartment-specific PAK4 regulation exists\", \"In vivo substrate phosphoproteomics across tissues is lacking\", \"Whether PAK4's kinase-independent scaffolding functions extend beyond RhoU stabilization and caspase-8 inhibition is unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2, 9, 11, 14, 19, 20, 23, 29, 30, 35, 37, 39, 41]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 24]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [9, 11, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [14, 22, 36, 43]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14, 43]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [12, 42]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 6, 32, 34, 41, 44]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [12, 23, 42]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [14, 27, 33, 36]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 15, 16]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"complexes\": [\n      \"Afadin/nectin junctional complex\",\n      \"Par6B/aPKC polarity complex\"\n    ],\n    \"partners\": [\n      \"CDC42\",\n      \"LIMK1\",\n      \"WASL\",\n      \"PXN\",\n      \"CTNNB1\",\n      \"AFDN\",\n      \"SETD6\",\n      \"RHOU\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}